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Abstract
Purpose: Interleukin 6 (IL-6) and the acute phase C-reactive protein (CRP) blood concentrations after lumbar spine
fusion may be affected by age. The purpose of this prospective observational study was to assess postoperative serum
levels of pro-inflammatory IL-6 and CRP after instrumented lumbar spine fusion surgery. We hypothesized that older
patients would have increased levels of IL-6 and CRP after surgery. Methods: IL-6 and high-sensitive CRP biochemical
marker levels were measured before instrumented spinal fusion, and postoperatively at 1 and 3 days, 6 weeks, and
3 months. The 49 patients in this sample were divided into two groups: age  60 years (n ¼ 23) and age > 60 years
(n ¼ 26). Results: Acute changes in IL-6 high-sensitivity and CRP from preoperative levels to postoperative day (POD) 1
increased with age. Mean (95% CI) difference between the age-groups in changes of IL-6 at PODs 1 and 3 was 45 pg/ml
(10–83, p ¼ 0.014) and 20 pg/ml (5–36, p ¼ 0.021), respectively. Mean (95% CI) difference between groups in changes of
CRP at PODs 1 and 3 was 9.6 mg/l (3.5 to 22.7, p¼ 0.47) and 24.8 mg/l (17 to 67, p¼ 0.33), respectively. Both groups
had decreased IL-6 and CRP levels at 6 weeks after surgery compared to the preoperative level. Conclusions: Elevation
of IL-6 and CRP is stronger in patients over 60 years old after instrumented lumbar spinal fusion. The CRP and IL-6 are
sensitive markers for acute postoperative inflammation. Even high acute CRP values do not necessarily indicate post-
operative infection.
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Introduction
Spinal pathologies can cause significant pain and impair-
ment. In severe lumbar spine pathologies and cases where
conservative treatment has failed, spinal fusion in combi-
nation with decompression can decrease the level of dis-
ability and pain as well as increase patients’ health-related
quality of life.1–3 However, surgical trauma activates endo-
crine, metabolic, and inflammatory responses.4 Local
infection control and healing process after spinal fusion is
achieved through the inflammatory response where pro-
inflammatory cytokines promote healing. One of these
cytokines is interleukin 6 (IL-6), which is produced by cells
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in the immune system.5,6 IL-6 functions in mediating sys-
temic inflammation that induces the production of acute
phase C-reactive protein (CRP) in liver hepatocytes.7–10
A rise in serum IL-6 and CRP concentration following
spinal surgery correlates with the magnitude of tissue
trauma caused by the procedure.11–15 Biochemical marker
concentrations are higher in patients after instrumented
spinal fusion than they are in patients without instrumenta-
tion.9,10 CRP levels are widely used also for detecting sur-
gical site infection after spinal fusion.10,16–18
In addition to surgical trauma and infection, the patient’s
age may influence the intensity of the inflammatory
response. Increased levels of CRP, IL-6, and tumor necro-
sis factor alpha can be found in healthy older individuals
compared with younger persons.19,20 IL-6 response after
hip surgery increases with older age.21 Age-related pro-
inflammatory state can be caused by cardiovascular risk
factors and increased morbidity with aging.20 Furthermore,
accumulation of intra-abdominal adipose tissue elevates
IL-6 and CRP levels in older people.22 However, no data
have been available on the interactions between IL-6 and
CRP levels with age in patients who have undergone instru-
mented lumbar spinal fusion. After lumbar spinal fusion,
these markers might be affected by age.
The aim of this study was to assess whether increased
postoperative IL-6 and CRP serum levels after instrumen-
ted lumbar spinal fusion surgery are related to age.
Materials and methods
This study hypothesized that older patients would have
increased levels of CRP and high-sensitivity C-reactive
protein (hs-CRP) after instrumented lumbar fusion sur-
gery compared to those of younger patients. Patients
aged 18 or more with successful blood samples were
included. Patients with inflammatory diseases or severe
cardiovascular, psychiatric, social, or general health dis-
orders were excluded from this study. Results are
reported adhering to the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE)
statement. The ethics committee of Tampere University
Hospital approved the study protocol.
Patients
Altogether 52 consecutive patients who underwent an elec-
tive instrumented lumbar spine fusion and decompression at
Tampere University Hospital were recruited for the study. All
participants signed an informed consent. Blood samples were
collected successfully from 49 of the 52 patients: 3 spinal
stenosis patients, 11 isthmic spondylolisthesis patients, and
35 degenerative spondylolisthesis patients. Diagnosis was
based on magnetic resonance imaging obtained of patients
in a supine position and plain radiographs obtained in a stand-
ing position. The main indication for surgery was radicular
lower extremity pain. All patients underwent treatment with
instrumented open posterolateral lumbar spine fusion using a
midline approach. The length of the fusion was one or two
level fusion for 35 patients and more than two levels for 14
patients. In addition, transforaminal lumbar interbody fusion
was used in 12 patients. Patients were divided into two
groups: age 60 years and age > 60 years (Table 1). Patients
did not receive glucocorticoid or immunomodulatory medi-
cation during the follow-up. There were no postoperative
infections in the study group during the 3 months’ follow-
up time based on clinical observations. All operations were
performed under general anesthesia.
Questionnaire compilation
Participants were asked about the duration of their preo-
perative symptoms, back pain, and radicular pain at the
time of admission. In addition to participants’ sociodemo-
graphic data, the questionnaire addressed height, weight,
medical conditions, current medication, tobacco use, and
received treatments. The Finnish version of the Oswestry
disability index (ODI)23 was used to assess participants’
back-specific disability level.
Blood samples
Blood samples were collected pre- and postoperatively
between April 2010 and November 2011 at Tampere Uni-
versity Hospital. All samples were collected in the morning
before breakfast (fasting blood tests): before surgery as







Age (years), mean (SD) 52.2 (6.6) 71.0 (6.1) <0.001
Female, n (%) 15 (65) 21 (81) 0.33
BMI 29.4 (5.4) 28.1 (5.3) 0.42
Smokers, n (%) 5 (22) 1 (4) 0.086
Preoperative symptoms,
months, median (IQR)
24 (15) 24 (23) 0.56
Back pain (VAS) (months),
median (IQR)
57 (37) 64 (52) 0.29
Radiculating pain (VAS)
(months), median (IQR)
44 (29) 72 (46) 0.018
ODI score, mean (SD) 45 (14) 41 (13) 0.28
Diagnosis, n (%) < 0.001
Degenerative olisthesis 12 (52) 23 (88)
Spinal stenosis 0 (0) 3 (12)
Isthmic spondylolisthesis 11 (48) 0 (0)
Duration of the surgery (min),
mean (SD)
162 (39) 148 (41) 0.24
Blood loss (ml), mean (SD) 390 (182) 442 (413) 0.67
Dural tears, n (%) 4 (17) 3 (12) 0.69
Length of the fusion > 2 levels,
n (%)
3 (13) 11 (42) 0.030
IQR: interquartile range; SD: standard deviation; VAS: visual analogue scale.
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well as after surgery on PODs 1 and 3 at the hospital ward,
and 6 weeks and 3 months postoperatively in a follow-up at
the outpatient clinic. Blood was drawn from the antebra-
chial vein into serum vacuum tubes. Serum samples were
stored at 80C until assayed with the Immulite1000 ana-
lyzer (Siemens Healthineers Global, Siemens Healthcare
GmbH, Erlangen, Germany). Levels of IL-6 and hs-CRP
were measured. The hs-CRP accurately measures low
concentrations of CRP. It can, therefore, be used for accu-
rate assessment of inflammation level. Blood samples
were analyzed using Immulite1000 High Sensitivity CRP
test® and Immulite1000 IL6 test®. Measuring ranges were
0.1–60,000 pg/ml for IL-6 and 0.1–3780 mg/l for hs-CRP.
The detection limits were 2 pg/ml for IL-6 and 0.1 mg/l
for hs-CRP.
Statistics
Data are presented as means with standard deviations (SD),
medians with interquartile ranges (IQR), 95% confidence
intervals (95% CI), or as counts with percentages. Repeated
measures for continuous outcomes (IL-6 and CRP) were
analyzed using a generalized estimating equations (GEE)
model with the unstructured correlation structure. A possi-
ble nonlinear relationship between age and the IL-6 or the
hs-CRP values were assessed using 5-knot-restricted cubic
spline regression. Models included baseline value, sex, and
duration of the surgery as covariates. In cases where the
assumptions were violated (e.g. non-normality), a
bootstrap-type method was used (10,000 replications) to
estimate the standard error. The normality of variables
was evaluated by the Shapiro–Wilk W test. Difference
of one and at least two-level fusion was assessed using




The patients’ mean age was 71.8 years (range 49–93). Thir-
teen patients were male and 36 female. The mean (SD)
body mass index (BMI) was 28.7 (5.3). There was no sig-
nificant difference in BMI, gender, or the amount of smo-
kers between the age-groups (Table 1). However, patients
older than 60 years had longer periods of radiating leg pain
before operation than did patients younger than 60 years
(Table 1). Concerning the operation, there were no signif-
icant differences between the two groups in the duration of
the surgery, blood loss, or amount of dural tears (Table 1).
Biochemical markers
Acute changes in IL-6 from the preoperative level to POD 1
increased with age (Figure 1(a)). The level of IL-6
increased in both groups from the preoperative level to its
highest value at POD 1 and thereafter started to decrease,
though it was still elevated at POD 3. The increase was
higher in the older age-group. Mean (95% CI) difference
between the age-groups in changes of IL-6 at PODs 1 and 3
Figure 1. (a) Mean IL-6 values in lumbar spinal fusion surgery patients from preoperative to 6 weeks postoperatively. Adjusted for age,
leisure-time physical activity, body fat percentage, and smoking. Whiskers show 95% confidence intervals. Significant differences were
found between the age-groups in changes of IL-6 at POD 1 (p¼ 0.014) and POD 3 (p¼ 0.021). (b) Relationships of acute changes in IL-6
from preoperative to POD 1 as the function of age. The curves were derived from 5-knot restricted cubic splines regression models.
The models were adjusted for leisure-time physical activity, body fat percentage, and smoking. Gray area represents 95% confidence
intervals. IL-6: interleukin-6; POD: postoperative day.
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was 45 pg/ml (10 to 83, p¼ 0.014) and 20 pg/ml (5 to 36, p
¼ 0.021), respectively (Figure 1(a)). At 6 weeks after the
operation, IL-6 levels were at a normal (equal to preopera-
tive) level in both groups.
There was an increase in hs-CRP from the preoperative
level to POD 1 according to age (Figure 2(a)). The hs-CRP
level started to increase at POD 1 in both groups and
achieved its highest value on POD 3. Mean (95% CI) dif-
ference between groups in changes of hs-CRP on PODs 1
and 3 were 9.6 mg/l (3.5 to 22.7 mg/l, p ¼ 0.47) and 24.8
mg/l (17 to 67 mg/l, p ¼ 0.33), respectively. Thirteen of
the 49 patients had an hs-CRP level over 200 mg/l level
measured at POD 3. Furthermore, 11 of these patients were
over 60 years. At 6 weeks, hs-CRP levels had decreased to
the preoperative level in both groups (Figure 2(b)).
The correlation was the strongest between the changes
from baseline to POD 1 in IL-6 and hs-CRP levels
(r ¼ 0.65, 95% CI 0.46 to 0.85). There was a moderate
correlation between IL-6 change in POD 3 and hs-CRP
change in POD 3 (r ¼ 0.57, 95% CI 0.33 to 0.80),
between IL-6 change at POD 1 and hs-CRP change in
3 days (r ¼ 0.40, 95% CI 0.14 to 0.66). No correlation
was found between the changes from baseline to POD 3
for IL-6 and to POD 1 for hs-CRP levels (r ¼ 0.16, 95%
CI 0.14 to 0.47).
There was a statistically significant difference
(p ¼ 0.043) in the POD 3 IL-6 values patients who had
undergone one level fusion and those who had undergone at
least two level fusion. Other tested inflammation markers
in the predefine time points were non-significant.
Discussion
Spinal fusion surgery causes tissue trauma leading to an
acute inflammation reaction in all age-groups. In the pres-
ent study, the inflammatory response was stronger in
patients over 60 years, although the duration of the surgery
and blood loss were comparable between the two age-
groups. To the authors’ knowledge, the present study was
the first to investigate whether the levels of inflammatory
markers vary between older and younger patients after
instrumented lumbar spine fusion. Pro-inflammatory IL-6
and the acute-phase protein CRP are at present the key
components in the inflammatory response. In spinal sur-
gery, CRP values are used to evaluate the healing process
and the occurrence of postoperative complications such as
infection. In the present study, the peak value of IL-6 was
highest at POD 1 and the hs-CRP was the highest at POD 3
after the spinal fusion procedure, results which are in line
with previously published data.9,10 This was probably due
to the fact that the production of CRP is mediated by the
IL-6, a process that takes time. Overall, the inflammatory
response of older patients appeared to show higher levels of
IL-6 and CRP production.
The timing and quantity of the IL-6 and hs-CRP peak
concentrations depend on the extent of damaged tissue11–15
Figure 2. (a) Mean CRP values in lumbar spinal fusion surgery patients from preoperative to 6 weeks postoperatively. Adjusted for age,
leisure-time physical activity, body fat percentage, and smoking. Whiskers show 95% confidence intervals. There were no significant
differences noted between the age-groups in changes of hs-CRP on PODs 1 (p¼ 0.47) and POD 3 (p¼ 0.33). (b) Relationships of acute
changes in CRP from preoperative to POD 1 as the function of the age. The curves were derived from 5-knot restricted cubic splines
regression models. The models were adjusted for leisure-time physical activity, body fat percentage, and smoking. Gray area represents
95% confidence intervals. hs-CRP: high-sensitivity C-reactive protein; IL-6: interleukin-6; POD: postoperative day.
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and the strength of the inflammatory response.4,19 In gen-
eral IL-6 and CRP levels are higher after open surgery than
in minimally invasive lumbar spine fusion.11–15 Further-
more, the CRP and IL-6 values after instrumented spinal
fusion are higher than those after non-instrumented spinal
fusion or decompression-only surgery.9,10 In the present
study, all patients underwent open instrumented surgery
with midline approach and detachment and retraction of
extensor muscles, which results in high IL-6 and CRP lev-
els. In addition, there were 11 patients over 60 years on
whom more than two level fusions were performed. These
additional levels of fusion instrumentation could partly
explain the stronger inflammatory response.
In the present study, changes in serum concentrations of
CRP adhered to the IL-6 levels. CRP levels increase during
the first three PODs in patients who have undergone spinal
surgery.8,9 Interestingly, statistical significance was found
between the two age groups in the IL-6 levels but not in the
CRP levels. The absence of a rapid decline or secondary
rise in CRP levels after the acute phase indicates postopera-
tive infection.10,16–18 Serum IL-6 concentration increases
rapidly within 1 day after spinal surgery and decreases
within a week to the preoperative level.8 Thelander and
Larsson reported that CRP value reached its peak on POD
3 and decreased to a normal level over 14 days after instru-
mented posterior lumbar interbody fusion in patients with
uncomplicated surgery.12 IL-6 mediates the production of
CRP. This process can take time. Aono et al. reported that
19 of the 143 patients who had undergone posterior lumbar
interbody fusion in treatment of degenerative spinal disease
had a CRP level of 100 mg/l on POD 4.18 In the present
data, no postoperative infections were observed. At the
6-week follow-up, the hs-CRP values of all patients had
decreased back to the preoperative level.
A proper inflammatory reaction is essential for tissue
healing and infection control after surgery.24 However,
imbalance between pro- and anti-inflammatory mediators
increases the risk of postoperative infection.25 In addition
to weaker preoperative physical condition, the stronger
inflammatory response is one reason for slower functional
recovery.26 Aging is also connected with chronic low-grade
inflammation.27 Furthermore, visceral fat and intermuscu-
lar thigh fat has been shown to increase IL-6 and CRP
concentrations.28 The present study showed that in addition
to chronic inflammation, older patients had stronger acute
inflammatory reaction after lumbar spine fusion. The IL-6
concentration increased from the preoperative level to POD
1 along with the age of the patient. The same tendency was
noted in the hs-CRP concentrations during PODs 1–3. Mus-
cle mass decreases in the aging process. Thus, hypotheti-
cally, trauma caused by tissue stretching in the operation
should also decrease. It seems that, in addition to the extent
of the tissue trauma, sensitivity to surgical trauma, blood
loss, and perioperative stress might cause a stronger
inflammatory response in older patients who undergo
instrumented spinal fusion. In the present study, the
strongest correlation in inflammatory markers was in the
changes from baseline to POD 1 in IL-6 and hs-CRP levels.
An unexperienced physician may consider the rise of
CRP levels as an indication for infection. To the authors’
clinical experience, when the CRP values have risen above
150, an unnecessary antibiotic treatment may have had
initiated during the postoperative recovery phase after lum-
bar spine fusion surgery. CRP values reach their tip on the
POD 3 according to the report by Thelander and Larsson.12
The present study showed that the decrease in the IL-6
value was already noticeable on the POD 3 after decom-
pression and lumbar spine fusion. Considering these find-
ings, the rise of the CRP values should continue after POD
3 to indicate an underlying infection. The diagnostics of an
infection might be postponed as CRP should be measured
repeatedly. Based on the results presented here, rise in the
IL-6 level on POD 4 would indicate infection. Measuring
both the IL-6 and the CRP could give insight for absence or
presence of infection.
One of the strengths of this study was its prospective
setting, which allowed IL-6 and hs-CRP measurements at
distinct time points. Further, the study assessed pro-
inflammatory cytokine and acute phase protein as raw
laboratory values to bring deeper insight to the inflamma-
tion response after instrumented lumbar spine fusion. The
study used a comprehensive questionnaire compilation to
assess patients’ baseline health state. One could speculate
that patients’ visceral or body fat percentage could have
been assessed to eliminate bias. However, this was not the
scope of the study, and the two groups were comparable in
BMI values. The timing of taking the blood samples was
based on normal clinical practices just before hospital dis-
charge, and at 6-week and 3-month follow-ups. The blood
samples were obtained, for ethical as well as practical rea-
sons, in real clinical settings to guarantee that patients
would be inconvenienced as little as possible. The timing
was similar as in previously published studies,9–18 though
this study had a significantly longer follow-up for the final
blood sample than did studies with a similar scope. Three of
the 52 patients had to be excluded from the analyses as
blood samples were not obtained at every time point or
patients had already eaten their breakfast. The results are
generalizable to patients who have undergone instrumented
lumbar spine fusion and decompression. Nonetheless,
patients’ general condition,29 length of the fusion area, or
invasiveness of the surgery might have an impact to the
postoperative CRP values. As these factors were not spe-
cifically investigated in this study, future studies could
address this particular question.
Conclusions
The increase in IL-6 and hs-CRP concentrations after the
surgery is stronger in patients over 60 years of age. The
IL-6 and hs-CRP proved to be sensitive markers for acute
postoperative inflammation. Their concentrations returned
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to normal level 6 weeks after lumbar spine fusion in
patients without postoperative infection. Even high CRP
values do not necessarily indicate postoperative infection.
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